Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25564979 | 0.92 | KDM4E (0.33) | PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL10176059 | 0.86 | ALOX5 (0.40) | PRKDCPRMT5WDR77ATM | |
| SCHEMBL21599396 | 0.83 | PRKDC (0.33) | PRKDCKDM4EL3MBTL1 | |
| SCHEMBL18597478 | 0.81 | — | — | |
| SCHEMBL21993183 | 0.81 | PLA2G2A (0.38) | PRKDCKDM4EATML3MBTL1 | |
| SCHEMBL12138211 | 0.81 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL23616463 | 0.81 | ALOX5 (0.38) | PRKDCPRMT5WDR77ATM | |
| SCHEMBL18639440 | 0.80 | — | — | |
| SCHEMBL25705768 | 0.80 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL25766597 | 0.80 | KDM4E (0.37) | PRKDCKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120086329-A1 | Novel 3, 9-Linked Oliogocarbazole-Based Hosts, Containing DBT and DBF Fragments, Separated by Aromatic Spacers | Universal Disolay Corporation (US) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120086329-A1 | Novel 3, 9-Linked Oliogocarbazole-Based Hosts, Containing DBT and DBF Fragments, Separated by Aromatic Spacers | DBF4, OGFOD1, DDT | PRKDC 2338/4885PRMT5 3336/4885WDR77 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.